CueZen, an AI-based personalization engine for health, announced $5 million in funding led by Point72 Ventures, with participation from Pack VC, Fortson VC, and Nextinfinity.
What the funding will be used for: The funding will accelerate customer acquisition and expand CueZen’s platform capabilities so that health enterprises can personalize their digital offerings.
The funding will also help grow sales and AI teams, accelerate product development, and form strategic partnerships with leading health technology companies.
Value proposition: Health sector enterprises often face persistent challenges in driving meaningful user engagement, hindered by fragmented app data, a lack of clinically validated health programs, and rigid integration between sensors and digital solutions, leading to low user retention and missed revenue opportunities. And CueZen’s purpose-built AI platform directly addresses these challenges by seamlessly orchestrating sensor technologies with evidence-based health programs.
By addressing the gap between data collection and actionable interventions, CueZen empowers companies to boost user engagement, improve retention, and unlock new revenue opportunities. And its platform enhances customer lifetime value through personalized health programs tailored to areas like general wellness, women’s health, metabolic health, cardiovascular care, and sleep disorders.
KEY QUOTES:
“At CueZen, we are committed to making health and wellness truly personal – because that’s where real change begins. This investment is not just fuel for growth – it’s a signal of market readiness for AI that turns everyday lifestyle and clinical data into actions that help millions improve their health. We will leverage this capital to expand our enterprise partnerships, deepen platform capabilities, and unlock measurable ROI — all while delivering personalization in health at unprecedented scale.”
Ankur Teredesai, CEO and Co-Founder of CueZen
“We believe CueZen is addressing a significant gap in the digital health ecosystem. Their platform has the potential to fundamentally change how health data is leveraged across the industry. We’re impressed by the early impact they’ve demonstrated and are excited to support their vision of creating better health outcomes while enabling new revenue streams for technology companies and providers in this space.”
Tara Stokes, Partner at Point72 Ventures
